Wednesday, December 13, 2017 10:15 PM ET
Insider Selling at AxoGen (AXGN) Continues with Significant Sale
An insider — Jamie Mark Grooms, Director — sold 38,405 shares of AxoGen having a market value of approximately $1,011,806 today, as disclosed in a form 4 document filed with the SEC. There have been 3 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the sale of 2,384,295 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 2,422,700 shares and have averaged 605,675 shares per transaction over this time period.
During the last 90 days, the number of insider buy/sell trades at AxoGen is higher than the 91-company peer group average. Advanced Medical Equipment & Technology peer group saw 103 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for AxoGen insiders was also higher. Within the peer group there were 15,081,823 shares purchased and 3,366,424 shares sold with company insiders acquiring 216,952 shares on average.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data used in composing and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.